Skip to main content
Download PDF

Correction: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Cancer Nanotechnology volume 14, Article number: 68 (2023) Cite this article

The Original Article was published on 20 June 2023

Correction: Cancer Nanotechnology (2023) 14:65 https://doi.org/10.1186/s12645-023-00218-2

Following publication of the original article (Naseer et al. 2023), the below Acknowledgement was missing.

Acknowledgement

We gratefully acknowledge the technical and financial support of the Deanship of Scientific Research (DSR) provided at King Abdulaziz University, Jeddah, Saudi Arabia under Grant No. (FP-225-43).

The original article (Naseer et al. 2023) has been corrected.

Reference

Download references

Author information

Authors and Affiliations

  1. Industrial Biotechnology, Atta‑ur‑Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan

    Faiza Naseer, Kousain Kousar & Tahir Ahmad

  2. Shifa College of Pharmaceutical Sciences, Shifa Tameer e Millat University, Islamabad, Pakistan

    Faiza Naseer

  3. Immune Responses in Different Diseases Research Group, Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdul-Aziz University, Jeddah, 21589, Saudi Arabia

    Maisa S. Abduh

  4. Department of Biology, University of Hail, Hail, Saudi Arabia

    Sadia Anjum

Authors
  1. Faiza Naseer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kousain Kousar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maisa S. Abduh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sadia Anjum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tahir Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Faiza Naseer or Tahir Ahmad.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s12645-024-00278-y

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naseer, F., Kousar, K., Abduh, M.S. et al. Correction: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation. Cancer Nano 14, 68 (2023). https://doi.org/10.1186/s12645-023-00219-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12645-023-00219-1

Cancer Nanotechnology

ISSN: 1868-6966

Contact us